Publications

Journal Article Epublish 1 citations
Electronic publication date
June 19, 2025

View on Pubmed.gov 40535676 | View on doi.org 10.62347/UNVS81...

Analysis of cullin family genes in rectal adenocarcinoma: expression, prognostic significance, and therapeutic implications.

Search for publications in this journal Am J Transl Res - 17(5):3842-3861

Abstract

OBJECTIVES

Cullin family genes play a critical role in ubiquitin-mediated protein degradation and have been implicated in various cancers. However, their expression patterns, prognostic significance, and functional roles in rectal adenocarcinoma (READ) remain unclear. This study aims to comprehensively analyze the expression, prognostic value, and potential biological functions of culllin genes in READ.

METHODS

We analyzed the transcriptional expression of CUL1, CUL2, CUL3, CUL4A, CUL4B, CUL5, CUL7, and CUL9 in READ using publicly available databases, including UALCAN and HOA. The prognostic significance of CUL genes was evaluated using Kaplan-Meier survival analysis. Functional enrichment analysis was performed to determine the biological pathways associated with cullin gene expression. Additionally, siRNA-mediated knockdown of CUL genes was done to assess the effect on cell proliferation, migration, and colony formation.

RESULTS

The analysis revealed significant overexpression of cullin genes in READ compared to normal tissues. Survival analysis indicated that higher expression of specific CUL2 and CUL7 genes correlated with poor prognosis in READ patients. Functional enrichment analysis demonstrated that cullin genes were associated with diverse enrichment terms. In vitro experiments showed that siRNA-mediated knockdown of CUL2 and CUL47 led to a significant reduction in cell proliferation, migration, and colony formation, highlighting their potential oncogenic role in READ.

CONCLUSION

This study provides novel insight into the role of cullin genes in READ, suggesting that CUL2 and CUL7 may be biomarkers and therapeutic targets. Further research is warranted to explore their underlying mechanisms and clinical applications in READ management.

References

Cell Oncol (Dordr). 2023 Jun;46(3):545-570

Comput Biol Chem. 2021 Jun;92:107457

Leukemia. 2024 Dec;38(12):2699-2708

Cell Rep. 2020 Apr 7;31(1):107465

Conflict of interest statement

None.

MeSH

Specialties

Copyright

AJTR Copyright © 2025.